XML 68 R6.htm IDEA: XBRL DOCUMENT v3.2.0.727
CONSOLIDATED STATEMENTS OF CASH FLOW - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2015
Jun. 30, 2014
Jun. 30, 2013
OPERATING ACTIVITIES      
Net (loss) income $ (370,961) $ 162,198 $ 206,916
Adjustments for non-cash items:      
Depreciation 104,978 104,027 92,344
Amortization 26,686 26,195 20,760
Stock-based compensation expense 16,827 17,641 21,874
Restructuring and asset impairment charges (Notes 2 and 14) 548,028 3,408 0
Deferred income tax provision (48,575) 23,119 232
Other 2,098 2,106 2,577
Changes in certain assets and liabilities:      
Accounts receivable 46,552 (45,041) 33,801
Inventories 70,874 (5,310) 5,879
Accounts payable and accrued liabilities (8,218) 13,748 (90,449)
Accrued income taxes (10,163) (12,485) 949
Other (26,689) (17,733) (10,733)
Net cash flow provided by operating activities 351,437 271,873 284,150
INVESTING ACTIVITIES      
Purchases of property, plant and equipment (100,939) (117,376) (82,835)
Disposals of property, plant and equipment 16,122 1,236 3,016
Business acquisition, net of cash acquired (Note 4) 0 (634,615) (500)
Proceeds from sale of business 0 10,225 0
Other 263 356 (379)
Net cash flow used for investing activities (84,554) (740,174) (80,698)
FINANCING ACTIVITIES      
Net (decrease) increase in notes payable (63,647) 31,568 (833)
Net increase (decrease) in short-term revolving and other lines of credit 200 (3,600) (23,600)
Term debt borrowings 89,712 736,079 944,152
Term debt repayments (308,736) (450,928) (736,562)
Purchase of capital stock (318) (14,165) (121,408)
Sale of subsidary stock 0 0 26,665
Dividend reinvestment and the effect of employee benefit and stock plans 13,844 26,676 17,356
Cash dividends paid to Shareholders (56,979) (56,436) (51,011)
Other (7,039) 1,214 (2,612)
Net cash flow (used for) provided by financing activities (332,963) 270,408 52,147
Effect of exchange rate changes on cash and cash equivalents (6,355) (1,494) 5,251
CASH AND CASH EQUIVALENTS      
Net (decrease) increase in cash and cash equivalents (72,435) (199,387) 260,850
Cash and cash equivalents, beginning of period 177,929 377,316 116,466
Cash and cash equivalents, end of period $ 105,494 $ 177,929 $ 377,316